000 | 01560 a2200457 4500 | ||
---|---|---|---|
005 | 20250513153342.0 | ||
264 | 0 | _c19981217 | |
008 | 199812s 0 0 eng d | ||
022 | _a1018-9068 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChiu, Y Y | |
245 | 0 | 0 |
_aSC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients. _h[electronic resource] |
260 |
_bJournal of investigational allergology & clinical immunology _c |
||
300 |
_a239-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Antinuclear _xanalysis |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aBlood Sedimentation |
650 | 0 | 4 |
_aComplement C1 Inactivator Proteins _xanalysis |
650 | 0 | 4 |
_aComplement C1r _xanalysis |
650 | 0 | 4 |
_aComplement C3 _xanalysis |
650 | 0 | 4 |
_aComplement C3a _xanalogs & derivatives |
650 | 0 | 4 |
_aComplement C3b _xanalysis |
650 | 0 | 4 |
_aComplement C4 _xanalysis |
650 | 0 | 4 | _aComplement Membrane Attack Complex |
650 | 0 | 4 |
_aComplement System Proteins _xanalysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycoproteins _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
700 | 1 | _aNisihara, R M | |
700 | 1 | _aWürzner, R | |
700 | 1 | _aKirschfink, M | |
700 | 1 | _ade Messias-Reason, I J | |
773 | 0 |
_tJournal of investigational allergology & clinical immunology _gvol. 8 _gno. 4 _gp. 239-44 |
|
999 |
_c9742214 _d9742214 |